Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LC-MS Based Metabolomics Study of Coronary Heart Disease: Diagnostic and Prognostic Value of Metabolites

NCT05138731 is registered in ClinicalTrials.gov with General Hospital of Ningxia Medical University as lead sponsor.

NCT NCT05138731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05138731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LC-MS Based Metabolomics Study of Coronary Heart Disease: Diagnostic and Prognostic Value of Metabolites
Lead sponsor
General Hospital of Ningxia Medical University
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2020
Completion date
May 30, 2023
Enrollment
821 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

biomarkers